Agenus Accounts Payable from 2010 to 2025

AGEN Stock  USD 3.51  0.01  0.29%   
Agenus Accounts Payable yearly trend continues to be very stable with very little volatility. Accounts Payable is likely to grow to about 74.2 M this year. Accounts Payable is the amount Agenus Inc owes to suppliers or vendors for products or services received but not yet paid for. It represents Agenus' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2000-03-31
Previous Quarter
50.8 M
Current Value
45.9 M
Quarterly Volatility
14.7 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Agenus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Agenus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 16.4 M, Interest Expense of 118.2 M or Selling General Administrative of 95.1 M, as well as many indicators such as Price To Sales Ratio of 2.07, Dividend Yield of 0.0018 or Days Sales Outstanding of 72.0. Agenus financial statements analysis is a perfect complement when working with Agenus Valuation or Volatility modules.
  
Check out the analysis of Agenus Correlation against competitors.

Latest Agenus' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Agenus Inc over the last few years. An accounting item on the balance sheet that represents Agenus obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Agenus Inc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Agenus' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Agenus' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Agenus Accounts Payable Regression Statistics

Arithmetic Mean21,520,328
Geometric Mean7,352,775
Coefficient Of Variation121.46
Mean Deviation21,266,038
Median13,564,000
Standard Deviation26,138,443
Sample Variance683.2T
Range73.8M
R-Value0.89
Mean Square Error146.5T
R-Squared0.80
Slope4,910,174
Total Sum of Squares10248.3T

Agenus Accounts Payable History

202574.2 M
202470.7 M
202361.4 M
202240.9 M
202130.5 M
202017 M
201913.6 M

About Agenus Financial Statements

Agenus investors utilize fundamental indicators, such as Accounts Payable, to predict how Agenus Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts Payable70.7 M74.2 M
When determining whether Agenus Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agenus' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agenus Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agenus Inc Stock:
Check out the analysis of Agenus Correlation against competitors.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.02)
Revenue Per Share
7.808
Quarterly Revenue Growth
0.033
Return On Assets
(0.22)
Return On Equity
(12.79)
The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.